Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan
- Conditions
- Major Depressive Disorder (MDD)
- Registration Number
- NCT00330616
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
This is a study to obtain clinical experience of 323U66 SR for elderly patients with depression in repeat-dose of 323U66 SR up to 300mg/day, and to conduct exploratory investigation on safety, efficacy and pharmacokinetics profile in elderly patients with depression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) Total Score at Week 8 Baseline and Week 8 The Hamilton Rating Scale for Depression (HAM D) contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).
- Secondary Outcome Measures
Name Time Method Percentage Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) Total Score at Week 4 Baseline and Week 4 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).
Percentage Change From Baseline in Hamilton Rating Scale for Depression (HAM-D)Total Score at Week 8 Baseline and Week 8 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).
Percentage of Responders Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 4 Week 4 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Responders are defined as subjects that had a decrease of \>/= 50% total score on the HAM D.
Percentage of Responders Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 8 Week 8 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Responders are defined as subjects that had a decrease of \>/= 50% total score on the HAM D.
Percentage of Remitters Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 4 Week 4 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Remitters are defined as subjects with a HAM D total score of \</= 7.
Percentage of Remitters Based on the Hamilton Rating Scale for Depression (HAM-D) at Week 8 Week 8 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill). Remitters are defined as subjects with a HAM D total score of \</= 7.
Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) of Each Question's Score at Week 4 Baseline and Week 4 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).
Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) for Each Question's Score at Week 8 Baseline and Week 8 The Hamilton Rating Scale for Depression (HAM D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).
Percentage of Change From Baseline in Hamilton Rating Scale for Depression (HAM-D)for Each Question's Score at Week 4 Baseline and Week 4 The Hamilton Rating Scale for Depression (HAM-D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM-D score range from 0 (not ill) to 53 (severely ill).
Percentage of Change From Baseline in Hamilton Rating Scale for Depression (HAM-D) for Each Question's Score at Week 8 Baseline and Week 8 The Hamilton Rating Scale for Depression (HAM-D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).
Hamilton Rating Scale for Depression (HAM-D) Total Score at Week 4 and Week 8 Week 4 and Week 8 The Hamilton Rating Scale for Depression (HAM-D)contains 17 questions which detect change and measure illness severity. Individual items are rated on a scale of 0-4, 0-3, and 0-2 with total HAM D score range from 0 (not ill) to 53 (severely ill).
Percentage of Responders Based on the Clinical Global Impression - Global Improvement Score (CGI-I)at Week 4 and Week 8 Week 4 and Week 8 The CGI-I assesses the investigator's impression of the patient's current illness. The time span is the week before the rating and the score ranges from 1 (very much improved) to 7 (very much worse). Responders are subjects that have a score of 1 (very much improved) or 2 (much improved) on the CGI-I.
Change From Baseline in Clinical Global Impression (CGI) Severity of Illness Score at Weeks 1, 2, 3, 4, 8 Baseline, Weeks 1, 2, 3, 4, 8 The CGI-S assesses the investigator's impression of the severity of the patient's current illness. The time span is the week before the rating and the score ranges from 1 (normal, not at all ill) to 7 (among the most extremely ill patients).
Adverse Events (>=5% Incidence) Baseline through Week 8 Serious Adverse Events Baseline through Week 8
Trial Locations
- Locations (1)
GSK Investigational Site
🇯🇵Tokyo, Japan